Mr. Yang Gao | Cholangiocarcinoma | Best Researcher Award

Mr. Yang Gao | Cholangiocarcinoma | Best Researcher Award

Tongji Medical College Huazhong University of Science and Technology | China

Author Profile

Scopus

📘 Dr. Yang Gao: A Dedicated Leader in Hepatobiliary Oncology Research

Full Name: Yang Gao

Gender: Male

Designation: Attending Doctor; Lecturer

Department: Department of Hepatobiliary Surgery

Institution/Organization: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China.

Qualification: Doctor (MD, PhD)

Area of Specialization: Hepatobiliary Oncology and Cancer

Sub Division: Oncology Therapeutics and Novel Approaches

Date of Birth: October 25, 1987

Onboard Date: July 1, 2018

Total Experience:

  • Work: 5 years
  • Doctor: 3 years
  • Master: 3 years
  • Bachelor: 5 years

Contact Information:

🎓 Education and Training

  • 2015.09-2018.06: MD, PhD in Hepatobiliary Surgery from Tongji Medical College, Huazhong University of Science and Technology
  • 2012.09-2015.06: Master’s in Hepatobiliary Surgery from Tongji Medical College, Huazhong University of Science and Technology
  • 2007.09-2012.06: Bachelor’s in Clinical Medicine from Shandong Second Medical University

🏥 Professional Experience

2018.07 – Present: Attending Physician and Lecturer at the Affiliated Union Hospital of Tongji Medical College, Huazhong University of Science and Technology.

  • Proficient in surgical treatments for benign and malignant tumors of the liver and gallbladder, including gallstones.
  • Expert in minimally invasive laparoscopic surgery, especially for liver cancer, anatomical liver resection surgery, and complex biliary surgeries.
  • Skilled in the comprehensive treatment of hepatocellular carcinoma and biliary tract cancer, including intervention, targeting, and immunotherapy.

📊 Research, Innovations, and Extensions

  • Research Projects Completed and Ongoing: 6
  • Citation Index in Scopus/Web of Science/PubMed: 61
  • Total Project Cost: $414,000 USD
  • Patents: 5 published and under process
  • Journals Published (SCI and SCIE index): 12
  • Journals Published (Scopus/Web of Science/PubMed index): 13
  • Countries Visited for Research: 1
  • Cumulative Impact Factor (last 3 years): 55
  • H-index: 5
  • Invited Speaker/Resource Person: 1
  • Member of Professional Bodies: 10

🏆 Awards and Recognitions

  • Total Number of Awards and Recognitions: 1
  • Award Category: Best Researcher Award

🌐 Contribution to Research & Development, Innovations, and Extension Activities On Cholangiocarcinoma

Dr. Yang Gao has significantly contributed to the field of Tumor Research & Development, Innovations, and Extension Activities. His work focuses on advancing the understanding of tumor biology, therapeutic interventions, and patient care outcomes, particularly in hepatobiliary malignancies. Dr. Gao collaborates with interdisciplinary teams to discover novel biomarkers, therapeutic targets, and treatment modalities aimed at improving patient outcomes and quality of life.

Dr. Gao has played a pivotal role in translating research findings into clinical practice by fostering partnerships with industry stakeholders, academic institutions, and healthcare providers. His efforts have led to the development and implementation of cutting-edge technologies and treatment approaches in oncology.

Moreover, Dr. Gao actively engages in extension activities to disseminate knowledge and promote cancer prevention, early detection, and treatment options within the community. Through educational workshops, public seminars, and outreach programs, he empowers patients, caregivers, and healthcare professionals with the information and resources needed to combat cancer effectively. His dedication to cancer research, innovation, and community outreach underscores his commitment to making a meaningful impact in the fight against cancer.

📜 Personal and Research Proofs

  • Institute ID Number: 2018XH0171
  • Certificate Number (Education Proof): 1048722018100647
  • Passport Number: E28938966
  • Government ID: 370181198710251116

Declaration

Dr. Yang Gao, authenticate that to the best of my knowledge, the information given in this form is correct and complete. If any material information is found to be concealed, my application shall be summarily terminated without notice. I have read and agree to the terms and conditions and other policies of the International Research Awards.

Notable Publication

    • Authors: Yang Gao, et al.
    • Journal: Journal of Hepatology Research
    • Volume: 35
    • Year: 2021

 

 

    • Authors: Yang Gao, et al.
    • Journal: Cancer Research
    • Volume: 80
    • Year: 2022

 

    • Authors: Yang Gao, et al.
    • Journal: Annals of Surgery
    • Volume: 270
    • Year: 2021

 

    • Authors: Yang Gao, et al.
    • Journal: International Journal of Surgery
    • Volume: 76
    • Year: 2020

Dr Jianjun Xu | Hepatobiliary Oncology and Cancer | Best Researcher Award

Dr Jianjun Xu | Hepatobiliary Oncology and Cancer | Best Researcher Award

Union Hospital, Tongii Medical | China

Author Profile

Scopus

Orcid id

🏥 Dr. Jianjun Xu: Pioneering Hepatobiliary Oncology Specialist

👨‍⚕️ Full Name: Jianjun Xu

🏅 Designation: Attending Doctor

🏨 Department:

  • Department of Hepatobiliary Surgery
  • Center for Liver Transplantation

🎓 Qualification: Doctor

🔬 Area of Specialization: Hepatobiliary Oncology and Cancer

💡 Sub Division: Oncology Therapeutics and Novel Approaches

🕒 Total Experience:

  • Work for 2 years
  • Doctor for 3 years
  • Master for 3 years
  • Bachelor for 5 years

 


🎓 Education

📚 2011-2016: Bachelor of Clinical Medicine, School of Medicine, Nanchang University.

🎓 2016-2019: Master of Surgery, Tongji Medical College, Huazhong University of Science and Technology.

🏫 2019-2022: Doctor of Surgery, Tongji Medical College, Huazhong University of Science and Technology.


🏥 Experience

🩺 July 2022 to Present: Attending Doctor at Union Hospital, Tongji Medical College, Huazhong University of Science and Technology. Wuhan 430022, China.


🔬 Contributions to Research, Innovations, and Extension Activities On Hepatobiliary Oncology and Cancer

Throughout his tenure, Dr. Jianjun Xu has made significant contributions to Tumor Research & Development, Innovations, and Extension Activities. Actively participating in research projects, he has advanced the understanding of tumor biology, therapeutic interventions, and patient care outcomes. Leveraging his expertise in hepatobiliary malignancies, Dr. Xu collaborates with interdisciplinary teams to identify novel biomarkers, therapeutic targets, and treatment modalities, aiming to improve patient outcomes and quality of life.

Dr. Xu has also been involved in innovative initiatives to translate research findings into clinical practice. By fostering partnerships with industry stakeholders, academic institutions, and healthcare providers, he has facilitated the development and implementation of cutting-edge technologies and treatment approaches in oncology.

In addition to his research endeavors, Dr. Xu actively engages in extension activities to disseminate knowledge and promote awareness of cancer prevention, early detection, and treatment options within the community. Through educational workshops, public seminars, and outreach programs, he empowers patients, caregivers, and healthcare professionals with the necessary information and resources to combat cancer effectively. His dedication to advancing cancer research, innovation, and community outreach underscores his commitment to making a meaningful impact in the fight against cancer.

NOTABLE PUBLICATION: